C.T. Fitzpatrick
Vulcan Value Partners
Vulcan Value Partners Portfolio 13F
Vulcan Value Partners Holdings Activity
- Portfolio value:
- $11.23B≈ (+$339M≈)
- Previous value:
- $10.89B≈
- # of changes:
- 67
- New positions:
- 9
- Reported for:
- 31 Dec 2016 (Q4)
- Latest filing date:
- 14 Feb 2017
Vulcan Value Partners has disclosed a total of 67 changes to the portfolio in the (2016 Q4) SEC report(s): increased the number of shares of 16, bought 9 totally new, decreased the number of shares of 29 and completely sold out 13 position(s).
What stocks did Vulcan Value Partners buy in 2016 Q4?
During 2016 Q4 Vulcan Value Partners has bought 25 securities out of which top 5 purchases (by % change to portfolio) were (ORCL) Oracle Corp (added shares +1.34%), (MCK) McKesson Corp (added shares +105.32%), (COR) Cencora Inc (added shares +251.43%), (CVS) CVS Health Corp (new buy) and (V) Visa Inc, CL-A (added shares +1.67%).
In the 2016 Q4 report(s) the following changes have been made to the top investments: (ORCL) Oracle Corp (added shares +1.34%), (NOV) NOV Inc (reduced shares -11.19%), (AXS) AXIS CAPITAL HOLDINGS LTD (reduced shares -4.90%), (MCK) McKesson Corp (added shares +105.32%) and (ELV) Elevance Health Inc (reduced shares -3.53%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.